The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 17, 2018

Filed:

Sep. 22, 2016
Applicants:

Massachusetts Institute of Technology, Cambridge, MA (US);

The General Hospital Corporation, Boston, MA (US);

The Broad Institute, Inc., Cambridge, MA (US);

Inventors:

Richard O. Hynes, Winchester, MA (US);

Alexandra Naba, Cambridge, MA (US);

Karl Clauser, Boston, MA (US);

Steven A. Carr, Boxford, MA (US);

Kenneth Tanabe, Brookline, MA (US);

Assignees:

Massachusetts Institute of Technology, Cambridge, MA (US);

The General Hospital Corporation, Boston, MA (US);

The Broad Institute, Inc., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); A61K 49/00 (2006.01); A61K 51/00 (2006.01); A61K 47/68 (2017.01); A61K 51/10 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57492 (2013.01); A61K 47/6855 (2017.08); A61K 49/0002 (2013.01); A61K 51/1051 (2013.01); G01N 33/57415 (2013.01); G01N 2333/705 (2013.01);
Abstract

Proteomic methods for identifying cancer related proteins and related products and kits are provided. The cancer specific proteins are extracellular matrix proteins that are associated with various aspects of cancer. Panels or signature sets of proteins useful in the detection, diagnosis and treatment of cancers as well as monitoring therapeutic progress in a cancer patient are provided herein along with methods for their detection and for their use in targeting imaging and/or therapeutic agents to the tumors via binding to the specified proteins. The proteins were identified using proteomics analyzes of tissue samples taken from cancer patients. In certain aspects the proteins are particularly useful in colon cancer patients.


Find Patent Forward Citations

Loading…